Emerging Infectious Diseases (Oct 2023)
Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023
- Ana Hoxha,
- Steven M. Kerr,
- Henry Laurenson-Schafer,
- Nikola Sklenovská,
- Bernadette Basuta Mirembe,
- Ingrid Hammermeister Nezu,
- Patricia Ndumbi,
- Julia Fitzner,
- Maria Almiron,
- Marcelo Vila,
- Richard Pebody,
- Aisling M. Vaughan,
- Joana M. Haussig,
- Luis Alves de Sousa,
- Okot Charles Lukoya,
- Olaniyi Felix Sanni,
- Pierre Nabeth,
- Jeremias Domingos Naiene,
- Masaya Kato,
- Tamano Matsui,
- Krutika Kuppalli,
- Peter Omondi Mala,
- Rosamund F. Lewis,
- Olivier le Polain de Waroux,
- Boris I. Pavlin
Affiliations
- Ana Hoxha
- Steven M. Kerr
- Henry Laurenson-Schafer
- Nikola Sklenovská
- Bernadette Basuta Mirembe
- Ingrid Hammermeister Nezu
- Patricia Ndumbi
- Julia Fitzner
- Maria Almiron
- Marcelo Vila
- Richard Pebody
- Aisling M. Vaughan
- Joana M. Haussig
- Luis Alves de Sousa
- Okot Charles Lukoya
- Olaniyi Felix Sanni
- Pierre Nabeth
- Jeremias Domingos Naiene
- Masaya Kato
- Tamano Matsui
- Krutika Kuppalli
- Peter Omondi Mala
- Rosamund F. Lewis
- Olivier le Polain de Waroux
- Boris I. Pavlin
- DOI
- https://doi.org/10.3201/eid2910.230516
- Journal volume & issue
-
Vol. 29,
no. 10
pp. 2125 – 2129
Abstract
The 2022–2023 mpox outbreak predominantly affected adult men; 1.3% of reported cases were in children and adolescents <18 years of age. Analysis of global surveillance data showed 1 hospital intensive care unit admission and 0 deaths in that age group. Transmission routes and clinical manifestations varied across age subgroups.
Keywords
